A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)

Clinical trial NCT03040401 · UNKNOWN

Trial details

NCT number: NCT03040401
Sponsor: Vastra Gotaland Region
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myelomonocytic, Chronic

Start date: 2017-02-15
Primary completion: 2018-12-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.